Deferasirox
Tier B — Position earlyDeferasirox
Targets：Not applicable
Brand：Exjade, Jadenu, Exjade/Jadenu
Indications (approved)：Thalassaemia, Iron overload, Beta thalassaemia
Regional status
Synthetic routes & intermediates2 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| DEFE-005 | 74511-44-7 | 2-(benzyloxy)benzonitrile |
| DEFE-006 | 1492958-95-8 | methyl 2-(benzyloxy)benzimidate hydrochloride |
| DEFE-007 | 1492958-41-4 | methyl 2-(benzyloxy)benzimidate |
| DEFE-008 | 1441-87-8 | 2-hydroxybenzoyl chloride |
| DEFE-009 | 1492957-96-6 | 2-(2-(benzyloxy)phenyl)-4H-benzo[e][1,3]oxazin-4-one |
| DEFE-010 | 619-67-0 | 4-hydrazinylbenzoic acid |
Frequently asked questions
What are the approved indications of Deferasirox?
Approved indications include: Thalassaemia, Iron overload, Beta thalassaemia.
When does the Deferasirox patent expire?
No public expiry year is available for Deferasirox yet; this page updates once verified.
How many synthesis routes are recorded for Deferasirox?
2 synthesis routes are recorded; the shortest is 2 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Deferasirox intermediates?
All intermediates in Deferasirox routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Deferasirox intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29